Jade Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JBIO and other ETFs, options, and stocks.

About JBIO

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. 

CEO
Tom Frohlich
CEOTom Frohlich
Employees
55
Employees55
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2018
Founded2018
Employees
55
Employees55

JBIO Key Statistics

Market cap
927.25M
Market cap927.25M
Price-Earnings ratio
-5.58
Price-Earnings ratio-5.58
Dividend yield
—
Dividend yield—
Average volume
973.02K
Average volume973.02K
High today
$15.05
High today$15.05
Low today
$14.54
Low today$14.54
Open price
$14.92
Open price$14.92
Volume
634.24K
Volume634.24K
52 Week high
$28.00
52 Week high$28.00
52 Week low
$8.36
52 Week low$8.36

Stock Snapshot

Jade Biosciences(JBIO) stock is priced at $14.59, giving the company a market capitalization of 927.25M. It carries a P/E multiple of -5.58.

On 2026-10-23, Jade Biosciences(JBIO) stock moved within a range of $14.54 to $15.05. With shares now at $14.59, the stock is trading +0.3% above its intraday low and -3.1% below the session's peak.

Trading volume for Jade Biosciences(JBIO) stock has reached 634.24K, versus its average volume of 973.02K.

The stock's 52-week range extends from a low of $8.36 to a high of $28.00.

The stock's 52-week range extends from a low of $8.36 to a high of $28.00.

JBIO News

TipRanks 10h
Jade Biosciences Advances First-in-Human RA Trial, Setting Up Early Read on Pipeline Value

Jade Biosciences, Inc. (JBIO) announced an update on their ongoing clinical study. Jade Biosciences, Inc. is running a Phase 1 study called “A Phase 1 Study of...

Investing.com 3d
Jade Biosciences delays Phase 3 trial start for JADE101 - Investing.com

...

Jade Biosciences delays Phase 3 trial start for JADE101 - Investing.com

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own JBIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.